A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic Function

Clinical trial NCT07428525 · COMPLETED

Trial details

NCT number: NCT07428525
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2025-03-14
Primary completion: 2026-02-26
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.